Training Example: EPOGEN (epoetin alfa) – Review the Data, Give Your Score & Compare to the Real AI Evaluation

Industry Context — Common BS Fingerprints in Medical Devices, Pharma & Biotech
Generic Claims: advancing human health, breakthrough innovation, life-changing therapies, transforming patient outcomes…
Red Flags: FDA cleared used interchangeably with FDA approved, clinical claims without published study citations, breakthrough claims for incremental improvements, regulatory status implied but not specified…
Semantic Drift Patterns: homepage claims breakthrough but pipeline page shows preclinical only, FDA approved claims but only for one indication, marketed broadly, claims clinical evidence but links to poster presentations not published studies, claims global reach but regulatory approvals are single-market…
Proof Expectations: specific regulatory clearance numbers (FDA 510(k), CE, TGA), published clinical trial results with ClinicalTrials.gov registration, ISO 13485 and GMP certification details, peer-reviewed publication citations…

EPOGEN (epoetin alfa)

(https://epogen.com) 📸 Data Snapshot: May 30, 2026

Analyze the raw signals below. How would a machine score this business’s credibility?

Here are the exact signals captured from up to six pages of the site — the same raw inputs the evaluation engine analyzed. They are grouped by signal type so you can weigh each the way the machine does.

🏗️ Semantic Structure — heading hierarchy & page identity (Info Density · Commodity Fingerprint)
HOMEPAGE EPOGEN® (epoetin alfa)|For Patients with Anemia due to CKD (https://epogen.com)
Title

EPOGEN® (epoetin alfa)|For Patients with Anemia due to CKD

Meta

EPOGEN® is a prescription medication that is used to treat anemia for people with CKD on dialysis by helping the body create more red blood cells.

H1 given to more than 2.8 million people*
H3 A well-studied treatment
H3 on dialysis with anemia
H3 What is EPOGEN®?
H3 Other potential benefits
H3 How EPOGEN® is given
H3 Side effects
H3 Important Safety Information
H3 Important Safety Information
H5 A well-studied treatment given to more than 2.8 million people* on dialysis with anemia
H6 Indication
NAV_HEADER EPOGEN® (epoetin alfa)| Managing Anemia for CKD (https://epogen.com/managing-anemia/)
Title

EPOGEN® (epoetin alfa)| Managing Anemia for CKD

Meta

Find information about anemia, chronic kidney disease, and what treatment options are available.

H1 You are now leaving EPOGEN.com
H3 What is anemia?
H3 What causes anemia?
H3 Treatment options
H3 What you can do
H3 Important Safety Information
H3 Important Safety Information
H6 Indication
NAV_HEADER EPOGEN® (epoetin alfa) | Resources (https://epogen.com/resources/)
Title

EPOGEN® (epoetin alfa) | Resources

Meta

Find additional resources, including EPOGEN® prescribing information, medication guide, and instructions for use.

H1 You are now leaving EPOGEN.com
H2 Looking for more information?
H2 Online resources
H3 EPOGEN® Prescribing Information
H3 EPOGEN® Medication Guide
H3 EPOGEN® Instructions for Use
H3 Important Safety Information
H3 Important Safety Information
H6 Indication
📝 The Narrative — clean text per page (Info Density · Semantic Coherence)
HOMEPAGE (https://epogen.com) EPOGEN® (epoetin alfa)|For Patients with Anemia due to CKD
−

[H3]

[H3] Important Safety Information

EPOGEN® may cause serious side effects that can lead to death, including:

For people with cancer:
In patients with breast, non-small cell lung, head and neck, lymphoid, and cervical cancers: Your tumor may grow faster and you may die sooner if you choose to take EPOGEN®.
Your healthcare provider will talk with you about these risks.
For all people who take EPOGEN®, including people with cancer or chronic kidney disease:

Serious heart problems, such as heart attack or heart failure, and stroke. You may die sooner if you are treated with EPOGEN® to increase red blood cells (RBCs) to near the same level found in healthy people.
Blood clots. Blood clots may happen at any time while taking EPOGEN®. If you are receiving EPOGEN® for any reason and are going to have surgery, talk with your healthcare provider about whether you need to take a blood thinner to lessen the chance of blood clots during or following surgery.
Call your healthcare provider or get medical help right away if you have any of these symptoms:

Chest pain
Trouble breathing or shortness of breath
Pain or swelling in your legs
A cool or pale arm or leg
Sudden confusion, trouble speaking, or trouble understanding others’ speech

Sudden numbness or weakness in your face, arm, or leg, especially on one side of your body
Sudden trouble seeing
Sudden trouble walking, dizziness, loss of balance or coordination
Loss of consciousness (fainting)
Hemodialysis vascular access stops working

If you decide to take EPOGEN®, your healthcare provider should prescribe the smallest dose that is necessary to reduce your chance of needing RBC transfusions.
If your hemoglobin level stays too high or goes up too quickly, this may lead to serious health problems which may result in death. These serious health problems may happen if you take EPOGEN®, even if you do not have an increase in your hemoglobin level.
Do not take EPOGEN® if you:
Have cancer and have not been counseled by your healthcare provider about treatment with EPOGEN®.
Have high blood pressure that is not controlled (uncontrolled hypertension).
Have been told by your healthcare provider that you have, or have ever had a type of anemia called Pure Red Cell Aplasia (PRCA) that starts after treatment with EPOGEN® or other erythropoietin medicines.
Have had a serious allergic reaction to EPOGEN®.
Pregnant women, breastfeeding women, and babies should not receive EPOGEN® from multidose vials.
Before taking EPOGEN®, tell your healthcare provider if you: have heart disease; have high blood pressure; have had a seizure or stroke; receive dialysis; or if you are pregnant or breastfeeding, or plan to become pregnant or breastfeed.
EPOGEN® may cause other serious side effects:
High blood pressure. High blood pressure is a common side effect of EPOGEN® in people with chronic kidney disease. Your blood pressure may go up or be difficult to control with blood pressure medication while taking EPOGEN®. This can happen even if you have never had high blood pressure before. Your healthcare provider should check your blood pressure often.
Seizures. If you have seizures while taking EPOGEN®, get medical help right away and tell your healthcare provider.
Antibodies to EPOGEN®. Your body may make antibodies to EPOGEN® that can block or lessen your body’s ability to make RBCs and cause you to have severe anemia. Call your healthcare provider if you have unusual tiredness, lack of energy, dizziness, or fainting. You may need to stop taking EPOGEN®.
Serious allergic reactions. Serious allergic reactions can cause a skin rash, itching, shortness of breath, wheezing, dizziness and fainting due to a drop in blood pressure, swelling around your mouth or eyes, fast pulse, or sweating. If you have a serious allergic reaction, stop using EPOGEN® and call your healthcare provider or get medical help right away.
Severe skin reactions. Signs and symptoms of severe skin reactions with EPOGEN® may include: skin rash with itching, blisters, skin sores, peeling, or areas of skin coming off. If you have any signs or symptoms of a severe skin reaction, stop using EPOGEN® and call your healthcare provider or get medical help right away.
Dangers of using EPOGEN® from multiple-dose vials (which contain benzyl alcohol) in newborns, infants, and pregnant or breastfeeding women. Benzyl alcohol has been shown to cause brain damage, other serious side effects, and death in newborn and premature babies. If you use EPOGEN® from multiple-dose vials you should not breastfeed for at least 2 weeks after the last dose.
Common side effects of EPOGEN® include:
Joint, muscle, or bone pain
Fever
Cough
Rash
Nausea
Dizziness

High blood sugar
Low potassium levels in the blood
Chills
Blood vessel blockage
Low white blood cells

Vomiting
Soreness of mouth
Itching
Headache
Muscle spasm
Trouble sleeping

Difficulty swallowing
Respiratory infection
Weight decrease
Depression
Redness and pain at the EPOGEN® injection site

These are not all the possible side effects of EPOGEN®. Tell your healthcare provider about any side effects that bother you or do not go away.
You are encouraged to report negative side effects of prescription drugs to the US Food and Drug Administration (FDA). Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

+

[H5]

[H3] Important Safety Information
EPOGEN® may cause serious side effects that can lead to death, including:
For people with cancer:
In patients with breast, non-small cell lung, head and neck, lymphoid, and cervical cancers: Your tumor may grow faster and you may die sooner if you choose to take EPOGEN®.
5790 chars
SUB-PAGE (https://epogen.com/managing-anemia/) EPOGEN® (epoetin alfa)| Managing Anemia for CKD
−

[H3]

[H3] Important Safety Information

EPOGEN® may cause serious side effects that can lead to death, including:

For people with cancer:
In patients with breast, non-small cell lung, head and neck, lymphoid, and cervical cancers: Your tumor may grow faster and you may die sooner if you choose to take EPOGEN®.
Your healthcare provider will talk with you about these risks.
For all people who take EPOGEN®, including people with cancer or chronic kidney disease:

Serious heart problems, such as heart attack or heart failure, and stroke. You may die sooner if you are treated with EPOGEN® to increase red blood cells (RBCs) to near the same level found in healthy people.
Blood clots. Blood clots may happen at any time while taking EPOGEN®. If you are receiving EPOGEN® for any reason and are going to have surgery, talk with your healthcare provider about whether you need to take a blood thinner to lessen the chance of blood clots during or following surgery.
Call your healthcare provider or get medical help right away if you have any of these symptoms:

Chest pain
Trouble breathing or shortness of breath
Pain or swelling in your legs
A cool or pale arm or leg
Sudden confusion, trouble speaking, or trouble understanding others’ speech

Sudden numbness or weakness in your face, arm, or leg, especially on one side of your body
Sudden trouble seeing
Sudden trouble walking, dizziness, loss of balance or coordination
Loss of consciousness (fainting)
Hemodialysis vascular access stops working

If you decide to take EPOGEN®, your healthcare provider should prescribe the smallest dose that is necessary to reduce your chance of needing RBC transfusions.
If your hemoglobin level stays too high or goes up too quickly, this may lead to serious health problems which may result in death. These serious health problems may happen if you take EPOGEN®, even if you do not have an increase in your hemoglobin level.
Do not take EPOGEN® if you:
Have cancer and have not been counseled by your healthcare provider about treatment with EPOGEN®.
Have high blood pressure that is not controlled (uncontrolled hypertension).
Have been told by your healthcare provider that you have, or have ever had a type of anemia called Pure Red Cell Aplasia (PRCA) that starts after treatment with EPOGEN® or other erythropoietin medicines.
Have had a serious allergic reaction to EPOGEN®.
Pregnant women, breastfeeding women, and babies should not receive EPOGEN® from multidose vials.
Before taking EPOGEN®, tell your healthcare provider if you: have heart disease; have high blood pressure; have had a seizure or stroke; receive dialysis; or if you are pregnant or breastfeeding, or plan to become pregnant or breastfeed.
EPOGEN® may cause other serious side effects:
High blood pressure. High blood pressure is a common side effect of EPOGEN® in people with chronic kidney disease. Your blood pressure may go up or be difficult to control with blood pressure medication while taking EPOGEN®. This can happen even if you have never had high blood pressure before. Your healthcare provider should check your blood pressure often.
Seizures. If you have seizures while taking EPOGEN®, get medical help right away and tell your healthcare provider.
Antibodies to EPOGEN®. Your body may make antibodies to EPOGEN® that can block or lessen your body’s ability to make RBCs and cause you to have severe anemia. Call your healthcare provider if you have unusual tiredness, lack of energy, dizziness, or fainting. You may need to stop taking EPOGEN®.
Serious allergic reactions. Serious allergic reactions can cause a skin rash, itching, shortness of breath, wheezing, dizziness and fainting due to a drop in blood pressure, swelling around your mouth or eyes, fast pulse, or sweating. If you have a serious allergic reaction, stop using EPOGEN® and call your healthcare provider or get medical help right away.
Severe skin reactions. Signs and symptoms of severe skin reactions with EPOGEN® may include: skin rash with itching, blisters, skin sores, peeling, or areas of skin coming off. If you have any signs or symptoms of a severe skin reaction, stop using EPOGEN® and call your healthcare provider or get medical help right away.
Dangers of using EPOGEN® from multiple-dose vials (which contain benzyl alcohol) in newborns, infants, and pregnant or breastfeeding women. Benzyl alcohol has been shown to cause brain damage, other serious side effects, and death in newborn and premature babies. If you use EPOGEN® from multiple-dose vials you should not breastfeed for at least 2 weeks after the last dose.
Common side effects of EPOGEN® include:
Joint, muscle, or bone pain
Fever
Cough
Rash
Nausea
Dizziness

High blood sugar
Low potassium levels in the blood
Chills
Blood vessel blockage
Low white blood cells

Vomiting
Soreness of mouth
Itching
Headache
Muscle spasm
Trouble sleeping

Difficulty swallowing
Respiratory infection
Weight decrease
Depression
Redness and pain at the EPOGEN® injection site

These are not all the possible side effects of EPOGEN®. Tell your healthcare provider about any side effects that bother you or do not go away.
You are encouraged to report negative side effects of prescription drugs to the US Food and Drug Administration (FDA). Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

+

[H5]

[H3] Important Safety Information
EPOGEN® may cause serious side effects that can lead to death, including:
For people with cancer:
In patients with breast, non-small cell lung, head and neck, lymphoid, and cervical cancers: Your tumor may grow faster and you may die sooner if you choose to take EPOGEN®.
5790 chars
SUB-PAGE (https://epogen.com/resources/) EPOGEN® (epoetin alfa) | Resources
−

[H3]

[H3] Important Safety Information

EPOGEN® may cause serious side effects that can lead to death, including:

For people with cancer:
In patients with breast, non-small cell lung, head and neck, lymphoid, and cervical cancers: Your tumor may grow faster and you may die sooner if you choose to take EPOGEN®.
Your healthcare provider will talk with you about these risks.
For all people who take EPOGEN®, including people with cancer or chronic kidney disease:

Serious heart problems, such as heart attack or heart failure, and stroke. You may die sooner if you are treated with EPOGEN® to increase red blood cells (RBCs) to near the same level found in healthy people.
Blood clots. Blood clots may happen at any time while taking EPOGEN®. If you are receiving EPOGEN® for any reason and are going to have surgery, talk with your healthcare provider about whether you need to take a blood thinner to lessen the chance of blood clots during or following surgery.
Call your healthcare provider or get medical help right away if you have any of these symptoms:

Chest pain
Trouble breathing or shortness of breath
Pain or swelling in your legs
A cool or pale arm or leg
Sudden confusion, trouble speaking, or trouble understanding others’ speech

Sudden numbness or weakness in your face, arm, or leg, especially on one side of your body
Sudden trouble seeing
Sudden trouble walking, dizziness, loss of balance or coordination
Loss of consciousness (fainting)
Hemodialysis vascular access stops working

If you decide to take EPOGEN®, your healthcare provider should prescribe the smallest dose that is necessary to reduce your chance of needing RBC transfusions.
If your hemoglobin level stays too high or goes up too quickly, this may lead to serious health problems which may result in death. These serious health problems may happen if you take EPOGEN®, even if you do not have an increase in your hemoglobin level.
Do not take EPOGEN® if you:
Have cancer and have not been counseled by your healthcare provider about treatment with EPOGEN®.
Have high blood pressure that is not controlled (uncontrolled hypertension).
Have been told by your healthcare provider that you have, or have ever had a type of anemia called Pure Red Cell Aplasia (PRCA) that starts after treatment with EPOGEN® or other erythropoietin medicines.
Have had a serious allergic reaction to EPOGEN®.
Pregnant women, breastfeeding women, and babies should not receive EPOGEN® from multidose vials.
Before taking EPOGEN®, tell your healthcare provider if you: have heart disease; have high blood pressure; have had a seizure or stroke; receive dialysis; or if you are pregnant or breastfeeding, or plan to become pregnant or breastfeed.
EPOGEN® may cause other serious side effects:
High blood pressure. High blood pressure is a common side effect of EPOGEN® in people with chronic kidney disease. Your blood pressure may go up or be difficult to control with blood pressure medication while taking EPOGEN®. This can happen even if you have never had high blood pressure before. Your healthcare provider should check your blood pressure often.
Seizures. If you have seizures while taking EPOGEN®, get medical help right away and tell your healthcare provider.
Antibodies to EPOGEN®. Your body may make antibodies to EPOGEN® that can block or lessen your body’s ability to make RBCs and cause you to have severe anemia. Call your healthcare provider if you have unusual tiredness, lack of energy, dizziness, or fainting. You may need to stop taking EPOGEN®.
Serious allergic reactions. Serious allergic reactions can cause a skin rash, itching, shortness of breath, wheezing, dizziness and fainting due to a drop in blood pressure, swelling around your mouth or eyes, fast pulse, or sweating. If you have a serious allergic reaction, stop using EPOGEN® and call your healthcare provider or get medical help right away.
Severe skin reactions. Signs and symptoms of severe skin reactions with EPOGEN® may include: skin rash with itching, blisters, skin sores, peeling, or areas of skin coming off. If you have any signs or symptoms of a severe skin reaction, stop using EPOGEN® and call your healthcare provider or get medical help right away.
Dangers of using EPOGEN® from multiple-dose vials (which contain benzyl alcohol) in newborns, infants, and pregnant or breastfeeding women. Benzyl alcohol has been shown to cause brain damage, other serious side effects, and death in newborn and premature babies. If you use EPOGEN® from multiple-dose vials you should not breastfeed for at least 2 weeks after the last dose.
Common side effects of EPOGEN® include:
Joint, muscle, or bone pain
Fever
Cough
Rash
Nausea
Dizziness

High blood sugar
Low potassium levels in the blood
Chills
Blood vessel blockage
Low white blood cells

Vomiting
Soreness of mouth
Itching
Headache
Muscle spasm
Trouble sleeping

Difficulty swallowing
Respiratory infection
Weight decrease
Depression
Redness and pain at the EPOGEN® injection site

These are not all the possible side effects of EPOGEN®. Tell your healthcare provider about any side effects that bother you or do not go away.
You are encouraged to report negative side effects of prescription drugs to the US Food and Drug Administration (FDA). Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

+

[H5]

[H3] Important Safety Information
EPOGEN® may cause serious side effects that can lead to death, including:
For people with cancer:
In patients with breast, non-small cell lung, head and neck, lymphoid, and cervical cancers: Your tumor may grow faster and you may die sooner if you choose to take EPOGEN®.
5790 chars
🛡️ Trust Signals — reviews, proof links, trust-theatre flag (Trust & Proof)
4Review mentions (all pages)
0External proof links (all pages)
PageReviewsProof links
/ (home) 1 0
/managing-anemia/ 2 0
/resources/ 1 0
🔗 Identity & Technical Layer — schema JSON-LD: identity chains, entity gaps (Identity & Authority)
Homepage — no schema detected (entity gap)
/managing-anemia/ — no schema detected (entity gap)
/resources/ — no schema detected (entity gap)

Your Diagnosis

Before revealing the machine’s verdict, predict the BS score for each signal. Higher = more BS (more fluff, less verifiable substance). Drag each slider, then submit to compare your judgment against the engine.

Information Density 0 / 30
Read the Narrative & headings: do hard facts (prices, dates, numbers) outweigh fluff power-words?
Semantic Coherence 0 / 20
Compare the homepage promise against the sub-page reality. Do they hold the same line?
Trust & Proof 0 / 20
Weigh review mentions against actual external proof links. Claims without verification = theatre.
Commodity Fingerprint 0 / 15
Check headings & narrative against the industry clichés in the setup above.
Identity & Authority 0 / 15
Inspect the schema: is there real Organization/Person identity with sameAs links, or gaps?
Your predicted BS score 0 / 100
💡 Stuck? Reveal the heuristic lens — how the deterministic page-auditor reads each signal (no AI, pure pattern rules)

These are the structural rules a local, deterministic auditor applies — the same lens you can use to judge each signal. They describe what to look for, not this company’s result.

Information Density

Classify each sentence as substantive or hollow. Grounding markers — numbers, currencies, dates, technical units, named entities — outweigh marketing adjectives. When fluff sits right next to hard evidence, the fluff is forgiven.

Semantic Alignment

Pull the main entities out of the H1, then check whether they actually recur through the body. A page that announces one thing and then talks about another drifts. Headings with no real sentences underneath read as pseudo-substance.

Trust & Proof

Count trust words (review, testimonial, rating, verified) against real outbound proof links (Google, Trustpilot, Clutch, G2, Yelp). Lots of trust language with zero verification links is trust theatre. Unlinked logo galleries count against it.

Commodity Fingerprint

Look at how much sentence length varies. Natural writing varies its rhythm; templated or mass-produced copy is statistically uniform. Very low variation reads as commodity content — unless unique named entities break the pattern.

Identity & Authority

Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.

Want to apply this lens yourself? The free BS Indicator Chrome extension runs these heuristic checks live on any page. Bear in mind it is a single-page, deterministic tool — it relies only on pattern rules for the page in front of it and does not perform the cross-page semantic correlation this audit uses, so its readout is a starting lens, not the full verdict.

B
BS Level
Medical Devices, Pharma & Biotech
40.7 Avg BS

Based on 784 businesses audited.

BS Detector

Medical Devices, Pharma & Biotech BS: EPOGEN (epoetin alfa) (epogen.com)

https://epogen.com 📍 Industry: Medical Devices, Pharma & Biotech
26 BS / 100

This is a low-BS pharmaceutical site where regulatory compliance has effectively strangled all marketing fluff. It is a ‘Substance-First’ site by necessity, prioritizing legal risk mitigation over creative claims.

Info Density Power-words vs. Substance ratio.
2
7% BS
Semantic Coherence Homepage promise vs. Sub-page reality.
0
0% BS
Trust & Proof Verifiable evidence vs. Trust Theatre.
10
50% BS
Commodity Fingerprint Detection of industry clichés/templates.
4
27% BS
Identity & Authority Expert verifiability & Schema depth.
10
67% BS

Implement comprehensive Drug and Organization schema to fix technical authority gaps. Add direct outbound links to ClinicalTrials.gov identifiers for the ‘well-studied’ claims. Include a ‘Our Scientists’ or ‘Medical Leadership’ section with Person schema and sameAs links to verify the human authority behind the brand. Replace the generic review metadata with verified clinician endorsements or summarized clinical study results.

The content perfectly aligns with the Pharma and Biotech industry. It focuses on a specific therapeutic area (anemia in CKD), uses medical terminology like epoetin alfa and hemodialysis, and adheres to strict FDA-regulated Important Safety Information (ISI) disclosure patterns.

“The score of 26 is primarily driven by technical implementation failures (missing schema) and trust theatre flags. The site is almost entirely free of semantic drift and information fluff, which are the heaviest contributors to high BS scores in other industries.”

Verified Analysis Date: May 30, 2026 © 1EuroSEO Independent Evaluator — Non-Sponsored Result
Brand AI Reputation